vs
Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $104.5M, roughly 1.4× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 3.6%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 5.1%).
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
IMCR vs RGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.5M | $151.1M |
| Net Profit | — | — |
| Gross Margin | 97.4% | 17.8% |
| Operating Margin | -18.8% | 2.3% |
| Net Margin | — | — |
| Revenue YoY | 24.3% | 3.6% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.61 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $104.5M | $151.1M | ||
| Q3 25 | $103.7M | $126.8M | ||
| Q2 25 | $98.0M | $132.5M | ||
| Q1 25 | $93.9M | $135.7M | ||
| Q4 24 | $84.1M | $145.8M | ||
| Q3 24 | $80.2M | $122.3M | ||
| Q2 24 | $75.4M | $130.8M | ||
| Q1 24 | $70.5M | $136.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-177.0K | $1.6M | ||
| Q2 25 | $-10.3M | $-17.2M | ||
| Q1 25 | $5.0M | $7.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.7M | $4.7M | ||
| Q2 24 | $-11.6M | $8.3M | ||
| Q1 24 | $-24.4M | $7.1M |
| Q4 25 | 97.4% | 17.8% | ||
| Q3 25 | 99.5% | 15.1% | ||
| Q2 25 | 98.9% | 3.9% | ||
| Q1 25 | 99.1% | 22.0% | ||
| Q4 24 | 99.6% | 22.8% | ||
| Q3 24 | 99.4% | 18.5% | ||
| Q2 24 | 97.7% | 22.3% | ||
| Q1 24 | 99.7% | 21.5% |
| Q4 25 | -18.8% | 2.3% | ||
| Q3 25 | -6.9% | -2.7% | ||
| Q2 25 | -15.2% | -15.6% | ||
| Q1 25 | -3.9% | 6.2% | ||
| Q4 24 | -23.1% | 7.8% | ||
| Q3 24 | -10.6% | 3.1% | ||
| Q2 24 | -21.2% | 6.9% | ||
| Q1 24 | -37.6% | 5.5% |
| Q4 25 | — | — | ||
| Q3 25 | -0.2% | 1.2% | ||
| Q2 25 | -10.5% | -13.0% | ||
| Q1 25 | 5.4% | 5.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.9% | 3.9% | ||
| Q2 24 | -15.4% | 6.3% | ||
| Q1 24 | -34.7% | 5.2% |
| Q4 25 | $-0.61 | $0.22 | ||
| Q3 25 | $0.00 | $0.10 | ||
| Q2 25 | $-0.20 | $-1.05 | ||
| Q1 25 | $0.10 | $0.46 | ||
| Q4 24 | $-0.47 | $0.62 | ||
| Q3 24 | $0.17 | $0.28 | ||
| Q2 24 | $-0.23 | $0.47 | ||
| Q1 24 | $-0.49 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $864.2M | $92.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $381.0M | $283.8M |
| Total Assets | $1.1B | $342.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $864.2M | $92.5M | ||
| Q3 25 | $892.4M | $80.8M | ||
| Q2 25 | $882.8M | $101.4M | ||
| Q1 25 | $837.0M | $108.3M | ||
| Q4 24 | $820.4M | $105.5M | ||
| Q3 24 | $901.3M | $96.0M | ||
| Q2 24 | $859.6M | $105.6M | ||
| Q1 24 | $832.8M | $115.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $438.7M | — | ||
| Q2 24 | $452.5M | — | ||
| Q1 24 | $452.5M | — |
| Q4 25 | $381.0M | $283.8M | ||
| Q3 25 | $396.6M | $279.6M | ||
| Q2 25 | $388.5M | $289.3M | ||
| Q1 25 | $378.5M | $321.5M | ||
| Q4 24 | $360.7M | $319.6M | ||
| Q3 24 | $377.8M | $314.9M | ||
| Q2 24 | $359.1M | $321.5M | ||
| Q1 24 | $359.5M | $332.0M |
| Q4 25 | $1.1B | $342.0M | ||
| Q3 25 | $1.1B | $342.3M | ||
| Q2 25 | $1.1B | $349.5M | ||
| Q1 25 | $1.0B | $379.0M | ||
| Q4 24 | $1.0B | $384.0M | ||
| Q3 24 | $1.1B | $373.5M | ||
| Q2 24 | $1.0B | $376.7M | ||
| Q1 24 | $994.0M | $385.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.26× | — | ||
| Q1 24 | 1.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-32.7M | $15.5M |
| Free Cash FlowOCF − Capex | $-35.5M | $12.3M |
| FCF MarginFCF / Revenue | -34.0% | 8.2% |
| Capex IntensityCapex / Revenue | 2.8% | 2.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-15.1M | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-32.7M | $15.5M | ||
| Q3 25 | $-4.5M | $12.9M | ||
| Q2 25 | $26.0M | $14.7M | ||
| Q1 25 | $435.0K | $11.1M | ||
| Q4 24 | $-14.0M | $20.0M | ||
| Q3 24 | $21.1M | $9.4M | ||
| Q2 24 | $23.5M | $18.7M | ||
| Q1 24 | $-4.6M | $7.3M |
| Q4 25 | $-35.5M | $12.3M | ||
| Q3 25 | $-5.2M | $7.0M | ||
| Q2 25 | $25.6M | $9.1M | ||
| Q1 25 | $137.0K | $10.0M | ||
| Q4 24 | $-17.5M | $16.4M | ||
| Q3 24 | $20.3M | $2.6M | ||
| Q2 24 | $23.1M | $10.1M | ||
| Q1 24 | $-5.0M | $5.6M |
| Q4 25 | -34.0% | 8.2% | ||
| Q3 25 | -5.0% | 5.5% | ||
| Q2 25 | 26.1% | 6.9% | ||
| Q1 25 | 0.1% | 7.4% | ||
| Q4 24 | -20.9% | 11.2% | ||
| Q3 24 | 25.3% | 2.1% | ||
| Q2 24 | 30.7% | 7.7% | ||
| Q1 24 | -7.1% | 4.1% |
| Q4 25 | 2.8% | 2.1% | ||
| Q3 25 | 0.7% | 4.6% | ||
| Q2 25 | 0.4% | 4.2% | ||
| Q1 25 | 0.3% | 0.8% | ||
| Q4 24 | 4.3% | 2.5% | ||
| Q3 24 | 1.0% | 5.5% | ||
| Q2 24 | 0.4% | 6.6% | ||
| Q1 24 | 0.6% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.09× | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.42× | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMCR
Segment breakdown not available.
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
